NDRA
ENDRA Life Sciences Inc.
Key Financials
Gross Profit
$0
NaN%
Net Income
$-7027410
↑ 38.9%
EPS (Diluted)
$-8.93
↑ 84.3%
Operating Income
$-5763101
↑ 46.7%
Revenue
$0
NaN%
Total Assets
$3.9M
↓ 13.4%
Total Liabilities
$1.6M
↓ 15.8%
Cash & Equivalents
$4.8M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 6/29/2026 | View on SEC |
| 425 | 6/26/2026 | View on SEC |
| 8-K | 6/26/2026 | View on SEC |
| 144 | 6/25/2026 | View on SEC |
| 425 | 6/25/2026 | View on SEC |
| 425 | 6/25/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| 8-K | 5/28/2026 | View on SEC |
| RW | 5/26/2026 | View on SEC |
| S-8 | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NDRA |
| Company Name | ENDRA Life Sciences Inc. |
| CIK | 1681682 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 734-335-0468 |